Form 4: Immunovant CTO Sells Shares
Insider Transaction (Form 4)
Jay S Stout, Chief Technology Officer of Immunovant, Inc., sold 3,809 shares of common stock on October 7, 2026 for $32.06 per share.
Summary
- Open-market sale: disposed of 2,213 Common Stock at $32.06 ($70,949) on October 7, 2026; holds 203,128 after (Direct).
- Open-market sale: disposed of 1,596 Common Stock at $32.06 ($51,168) on October 7, 2026; holds 201,532 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $122,117 of stock on the open market.
Insider Transactions
Jay S Stout — Officer (Chief Technology Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-07 | Open-market sale | Common Stock | 2,213 | $32 | $70.9K | 203,128 |
| 2026-10-07 | Open-market sale | Common Stock | 1,596 | $32 | $51.2K | 201,532 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-07 | Open-market sale (2,213 shares) |
| 2026-10-07 | Open-market sale (1,596 shares) |
Keywords
insider transaction, Form 4, IMVT, Immunovant, Inc., bearish, Jay S Stout
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.